Synaptogenix Performance
| SNPXDelisted Stock | USD 7.75 1.36 21.28% |
Synaptogenix holds a performance score of 19 on a scale of zero to a hundred. The entity has a beta of 2.68, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Synaptogenix will likely underperform. Use Synaptogenix potential upside, as well as the relationship between the accumulation distribution and price action indicator , to analyze future returns on Synaptogenix.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Synaptogenix are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Synaptogenix showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 28.7 M |
Synaptogenix |
Synaptogenix Relative Risk vs. Return Landscape
If you would invest 244.00 in Synaptogenix on April 28, 2025 and sell it today you would earn a total of 531.00 from holding Synaptogenix or generate 217.62% return on investment over 90 days. Synaptogenix is currently generating 3.3757% in daily expected returns and assumes 13.396% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Synaptogenix, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Synaptogenix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Synaptogenix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Synaptogenix, and traders can use it to determine the average amount a Synaptogenix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.252
| Best Portfolio | Best Equity | |||
| Good Returns | SNPX | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 13.4 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.38 actual daily | 68 68% of assets have lower returns |
Risk-Adjusted Return
| 0.25 actual daily | 19 81% of assets perform better |
Based on monthly moving average Synaptogenix is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Synaptogenix by adding it to a well-diversified portfolio.
Synaptogenix Fundamentals Growth
Synaptogenix Stock prices reflect investors' perceptions of the future prospects and financial health of Synaptogenix, and Synaptogenix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Synaptogenix Stock performance.
| Return On Equity | -0.83 | |||
| Return On Asset | -0.17 | |||
| Current Valuation | (2.79 M) | |||
| Shares Outstanding | 1.39 M | |||
| Price To Book | 2.08 X | |||
| EBITDA | (12.76 M) | |||
| Cash And Equivalents | 28.75 M | |||
| Cash Per Share | 4.20 X | |||
| Total Debt | 10.96 M | |||
| Book Value Per Share | 3.72 X | |||
| Cash Flow From Operations | (4.88 M) | |||
| Earnings Per Share | (10.46) X | |||
| Total Asset | 17.73 M | |||
| Retained Earnings | (47.17 T) | |||
About Synaptogenix Performance
Evaluating Synaptogenix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Synaptogenix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Synaptogenix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company was incorporated in 2012 and is headquartered in New York, New York. Synaptogenix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.Things to note about Synaptogenix performance evaluation
Checking the ongoing alerts about Synaptogenix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Synaptogenix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Synaptogenix is now traded under the symbol TAOX. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Synaptogenix is not yet fully synchronised with the market data | |
| Synaptogenix is way too risky over 90 days horizon | |
| Synaptogenix appears to be risky and price may revert if volatility continues | |
| Synaptogenix has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (12.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Synaptogenix currently holds about 28.75 M in cash with (4.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.2. |
- Analyzing Synaptogenix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Synaptogenix's stock is overvalued or undervalued compared to its peers.
- Examining Synaptogenix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Synaptogenix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Synaptogenix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Synaptogenix's stock. These opinions can provide insight into Synaptogenix's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Synaptogenix Stock
If you are still planning to invest in Synaptogenix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Synaptogenix's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |